Life Science Connect, a portfolio company of Latticework Capital and Edgehill Management, announced the purchase of biopharma service brands PharmaSource and CDMO Live. The deal merges PharmaSource with CDMO Live’s Europe and Americas divisions, creating a single outsourcing platform for drug developers.

Founded in 2023 by media entrepreneurs Luke Bilton and Chris Kilbee, Life Science Connect operates a network of go‑to‑work solutions linking professionals across life‑science communities. Bilton and Kilbee will remain senior vice presidents overseeing the new events division, ensuring continuity as the firm scales its service footprint.

The acquisition positions the combined entity to capture growing demand for contract development and manufacturing services, a segment that has expanded as pharma companies outsource more of their pipelines. By uniting Europe, Americas and external manufacturing capabilities, the platform can offer end‑to‑end solutions and leverage cross‑regional synergies.

Investors will watch how the enlarged platform drives revenue growth and operational efficiency, metrics that could influence future valuations for Latticework and Edgehill’s life‑science portfolio. The move underscores a broader trend of consolidation in the biotech services market, where scale increasingly determines competitive advantage.